Table 1.
Participant characteristics at baseline for Placebo and 400 mg ATP/d.*
| Placebo | 400 mg ATP/d | |
|---|---|---|
| Body Weight, kg |
|
|
| All |
71.0±10.3 |
70.9±10.4 |
| Females |
67.3±10.8 |
67.4±10.4 |
| Males |
74.7±8.9 |
74.4±9.7 |
| Body Fat, % |
|
|
| All |
18.9±8.3 |
18.7±9.8 |
| Females |
25.0±3.4 |
26.2±3.6 |
| Males |
12.9±7.2 |
11.2±8.0 |
| Body Mass Index |
|
|
| All |
23.3±2.5 |
23.3±2.7 |
| Females |
23.3±2.9 |
23.3±3.0 |
| Males | 23.3±2.3 | 23.2±2.5 |
*Studies were carried out on 16 participants (8 males and 8 females) with a mean age of 25.3 ± 3.9 years. Data are expressed as mean ± SD.